Teva was hit by another legal blow in the ongoing inhaler patent infringement saga with Amneal after an appellate court supported a previous ruling.
On 20 December, the US Court of Appeals for the Federal Circuit affirmed a lower district court decision, which was announced in June, ordering the Israeli firm to delist...